ALB vs EMN: stock comparison and AI forecast
Albemarle Corp (ALB) and Eastman Chemical Co (EMN) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ALB Albemarle Corp
- Price
- $98.37 -50.4% · 6M
- Market Cap
- $11.61B
- P/E Ratio
- 24.8x
- Size
- large-cap
- AI Forecast
EMN Eastman Chemical Co
- Price
- $65.71 -10.8% · 6M
- Market Cap
- $7.52B
- P/E Ratio
- 14.0x
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- ALB is 1.5 times larger than EMN by market capitalization ($11.61B against $7.52B).
- EMN trades at 13.9 times trailing earnings, ALB at 24.8 times.
- Over the last six months EMN returned -10.8% and ALB -50.4%.
- ALB turns 11.1% of its revenue into net income, against 7.2% for EMN.
- EMN carries 1.45 times debt per unit of equity, against 0.50 times for ALB.
- EMN yields 5.08% in dividends and ALB 3.56%.
- Both companies share the SEC industry classification Plastic Materials, Synth Resins & Nonvulcan Elastomers.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ALB | EMN |
|---|---|---|
| Market Cap | $11.61B | $7.52B |
| P/E Ratio | 24.78x | 13.95x |
| P/B Ratio | 1.10x | 1.20x |
| Dividend Yield | 3.56% | 5.08% |
| EPS | $3.97 | $4.71 |
| Book Value/Share | $89.33 | $54.87 |
| Revenue/Share | $52.14 | $79.10 |
| FCF/Share | $12.24 | $4.10 |
Profitability & Margins
| Metric | ALB | EMN |
|---|---|---|
| ROE | 6.5% | 10.3% |
| ROA | 4.2% | 4.2% |
| ROIC | 4.3% | – |
| Gross Margin | 25.8% | 20.6% |
| Operating Margin | 10.0% | – |
| Net Margin | 11.1% | 7.2% |
| EBT Margin | 11.9% | 7.2% |
| Tax Rate | 40.2% | 0.6% |
Financial Health
| Metric | ALB | EMN |
|---|---|---|
| Current Ratio | 2.34x | 1.57x |
| Quick Ratio | 1.57x | 0.79x |
| D/E Ratio | 0.50x | 1.45x |
| Financial Leverage | 1.53x | 2.46x |
| Interest Coverage | – | -16.5x |
| Working Capital | $2.43B | $1.59B |
Cash Flow
| Metric | ALB | EMN |
|---|---|---|
| Operating Cash Flow | $1.85B | $879M |
| Free Cash Flow | $1.44B | $469M |
| Capital Spending | -$406M | -$410M |
| OCF Growth YoY | 106.9% | -12.8% |
| FCF Growth YoY | 1284.7% | 18.7% |
| FCF/Sales | 23.5% | 5.2% |
| CapEx/Sales | 6.6% | 4.5% |
Operational Efficiency
| Metric | ALB | EMN |
|---|---|---|
| Asset Turnover | 0.38x | 0.59x |
| Receivables Turnover | 10.2x | 8.5x |
| Inventory Turnover | 3.3x | 3.3x |
| Fixed Assets Turnover | 0.7x | 1.6x |
| Days Sales Outstanding | 36 days | 43 days |
| Days Inventory | 111 days | 111 days |
Income Statement
| Metric | ALB | EMN |
|---|---|---|
| Total Revenue | $6.15B | $9.05B |
| Operating Income | $617M | – |
| Net Income | $682M | $647M |
| R&D Expense | $33M | $246M |
| SG&A Expense | $556M | $693M |
| Cost of Goods Sold | $4.56B | $7.19B |
Dividend & Shareholder Information
| Metric | ALB | EMN |
|---|---|---|
| Dividends Per Share | $3.50 | $3.34 |
| Payout Ratio | 88.2% | 70.9% |
| Shares Outstanding | 118M | 114M |
| Net Income Growth | – | -7.4% |
| EPS Growth | – | -21.2% |
ALB vs EMN: stock comparison and AI forecast
Which is bigger, ALB or EMN?
ALB is 1.5 times larger than EMN by market capitalization ($11.61B against $7.52B).
Which is cheaper on earnings, ALB or EMN?
EMN trades at 13.9 times trailing earnings, ALB at 24.8 times.
Which stock performed better over the last six months, ALB or EMN?
Over the last six months EMN returned -10.8% and ALB -50.4%.
Which one does Intratio's AI model rank higher, ALB or EMN?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.